BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9362162)

  • 21. [Change in the glandular bodies of the breast after hormone therapy. Observations from the radiologic viewpoint].
    Lendvai-Viragh K; Ritzkowsky D
    Aktuelle Radiol; 1994 Sep; 4(5):264-7. PubMed ID: 7986847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unilateral increase in mammographic density with hormone replacement therapy.
    Doyle GJ; McLean L
    Clin Radiol; 1994 Jan; 49(1):50-1. PubMed ID: 8299332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Byers T; Trujillo S; Hines L
    J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme.
    Litherland JC; Evans AJ; Wilson AR
    Clin Radiol; 1997 Apr; 52(4):276-9. PubMed ID: 9112944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast density changes associated with hormone replacement therapy in postmenopausal women. Effects on the specificity and sensitivity of mammographic screening.
    Patella A; Marziani R; Schippa A; Benedetti S; Mossa S; Mossa B
    Eur J Gynaecol Oncol; 2005; 26(5):485-90. PubMed ID: 16285562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is estrogen therapy of significance for the incidence of breast cancer?].
    Bakken K
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2801; author reply 2801. PubMed ID: 15534689
    [No Abstract]   [Full Text] [Related]  

  • 28. Mammographic density and breast cancer risk.
    van Gils CH
    Eur J Obstet Gynecol Reprod Biol; 1999 Oct; 86(2):127-8. PubMed ID: 10509777
    [No Abstract]   [Full Text] [Related]  

  • 29. Biological significance of interventions that change breast density.
    Chlebowski RT; McTiernan A
    J Natl Cancer Inst; 2003 Jan; 95(1):4-5. PubMed ID: 12509389
    [No Abstract]   [Full Text] [Related]  

  • 30. Mammographic density, response to hormones, and breast cancer risk.
    Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
    J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in mammography and breast ultrasonography in women undergoing hormonal replacement therapy].
    Rzymski P; Szpakowska-Rzymska I; Wilczak M; Warenik-Szymankiewicz A; Sajdak S
    Ginekol Pol; 2001 Oct; 72(10):809-15. PubMed ID: 11848018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices.
    LeBlanc ES; Viscoli CM; Henrich JB
    J Womens Health Gend Based Med; 1999; 8(6):815-23. PubMed ID: 10495262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Breast cytology guidelines for a mammographic screening program. Report edited by the working group on "Breast Pathology in the Mammographic Screening Program" of the European Union].
    Sapino A; Bianchi S; Bussolati G
    Pathologica; 1999 Jun; 91(3):203-8. PubMed ID: 10536467
    [No Abstract]   [Full Text] [Related]  

  • 34. Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
    Beral V; Banks E; Reeves G; Wallis M
    Lancet; 1997 Apr; 349(9058):1103-4. PubMed ID: 9107273
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of hormone replacement therapy on cancer detection by mammography.
    Cohen ME
    Lancet; 1997 May; 349(9065):1624. PubMed ID: 9174578
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
    Topal NB; Ayhan S; Topal U; Bilgin T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone replacement therapy and the breast.
    Dixon JM
    BMJ; 2001 Dec; 323(7326):1381-2. PubMed ID: 11744551
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of hormone replacement therapy on mammographic findings.
    Bülbül NH; Ozden S; Dayicioglu V
    Arch Gynecol Obstet; 2003 Apr; 268(1):5-8. PubMed ID: 12673467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.